Evidence map›Paper›PMID 33916001›Full record

ArticleCells2021

Alterations in the Gut-Microbial-Inflammasome-Brain Axis in a Mouse Model of Alzheimer's Disease.

Pradeep K Shukla, David F Delotterie, Jianfeng Xiao, Joseph F Pierre, RadhaKrishna Rao, Michael P McDonald, Mohammad Moshahid Khan

Open access · goldAbstract read
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 1 synthesis or guideline pooled it, 95 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Pradeep K ShuklaDepartment of Physiology, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA.ORCID 0000-0003-2515-9766
David F DelotterieDepartment of Neurology, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA.ORCID 0000-0001-9125-6746
Jianfeng XiaoDepartment of Neurology, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Joseph F PierreDepartment of Pediatrics, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
RadhaKrishna RaoDepartment of Physiology, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Michael P McDonaldDepartment of Neurology, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Mohammad Moshahid KhanDepartment of Neurology, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA.ORCID 0000-0003-4679-294X
University of Tennessee Health Science Center · US

Funding

Examining Progression of a Neurodegenerative DisorderR03NS114616 · NINDS · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI KHAN, MOHAMMAD MOSHAHID · 2020 to 2020
$152k
NINDS NIH HHS R03 NS114616
6 · The paper itself

Abstract

Alzheimer's disease (AD), a progressive neurodegenerative disorder characterized by memory loss and cognitive decline, is a major cause of death and disability among the older population. Despite decades of scientific research, the underlying etiological triggers are unknown. Recent studies suggested that gut microbiota can influence AD progression; however, potential mechanisms linking the gut microbiota with AD pathogenesis remain obscure. In the present study, we provided a potential mechanistic link between dysbiotic gut microbiota and neuroinflammation associated with AD progression. Using a mouse model of AD, we discovered that unfavorable gut microbiota are correlated with abnormally elevated expression of gut NLRP3 and lead to peripheral inflammasome activation, which in turn exacerbates AD-associated neuroinflammation. To this end, we observe significantly altered gut microbiota compositions in young and old 5xFAD mice compared to age-matched non-transgenic mice. Moreover, 5xFAD mice demonstrated compromised gut barrier function as evident from the loss of tight junction and adherens junction proteins compared to non-transgenic mice. Concurrently, we observed increased expression of NLRP3 inflammasome and IL-1β production in the 5xFAD gut. Consistent with our hypothesis, increased gut-microbial-inflammasome activation is positively correlated with enhanced astrogliosis and microglial activation, along with higher expression of NLRP3 inflammasome and IL-1β production in the brains of 5xFAD mice. These data indicate that the elevated expression of gut-microbial-inflammasome components may be an important trigger for subsequent downstream activation of inflammatory and potentially cytotoxic mediators, and gastrointestinal NLRP3 may promote NLRP3 inflammasome-mediated neuroinflammation. Thus, modulation of the gut microbiota may be a potential strategy for the treatment of AD-related neurological disorders in genetically susceptible hosts.

Indexed as

Gastrointestinal MicrobiomeAgingAlzheimer DiseaseAnimalsApoptosisBrainCARD Signaling Adaptor ProteinsCaspase 1Disease Models, AnimalGasderminsGastrointestinal TractInflammasomesInflammationInterleukin-1betaIntracellular Signaling Peptides and ProteinsMaleCARD Signaling Adaptor ProteinsCaspase 1GasderminsGsdmd protein, mouseInflammasomesInterleukin-1betaIntracellular Signaling Peptides and ProteinsNLR Family, Pyrin Domain-Containing 3 ProteinPhosphate-Binding ProteinsPycard protein, mousealzheimer’s diseaseamyloid-betagut microbiotaneuroinflammationNLRP3 inflammasome

Identifiers

PMID33916001
PMCPMC8067249
OpenAlexW3147763922

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.